KRYS
#907
Krystal Biotech, Inc. - Common Stock
331.6 1 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.32%
Changement Mensuel
-5.46%
Evolution sur 6 mois
+27.98%
Changement Annuel
+77.21%
Clôture Précédente
327.3 0
Open
326.5 5
Low
323.8 7
High
333.4 4
Financials
- Market Capitalization 9.82 B
- Employee 295
- Founded 2016
- CEO N/A
- Website www.krystalbio.com
- Headquarter Pennsylvania, United States
- FIGI BBG00HDGRHH7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
36.04
ratio cours/chiffre d'affaires
18.98
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 859 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.80 USD | -0.16% | -4.04% | -17.59% | +4.68% | 10.61 B USD | ||
| 890 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.78 USD | +1.31% | +5.02% | +2.43% | +101.24% | 10.15 B USD | ||
| 931 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 112.40 USD | +2.84% | +3.71% | -3.10% | +90.19% | 9.35 B USD | ||
| 933 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 143.73 USD | +2.73% | +2.04% | -4.13% | +91.31% | 9.30 B USD |